News Releases & Media

Rocket Pharmaceuticals Reports Full Year 2017 Financial Results and Operational Highlights

March 6th, 2018

Click to download press release

Rocket Pharmaceuticals to Present at the Cowen & Company 38th Annual Health Care Conference

March 5th, 2018

Click to download press release

Rocket Pharmaceuticals Announces Participation in a Fireside Chat at the Leerink Partners 7th Annual Global Healthcare Conference

Februrary 7th, 2018

Click to download press release

Rocket Pharmaceuticals Prices Public Offering of Common Stock

January 24th, 2018

Click to download press release

Rocket Pharmaceuticals Announces Proposed Public Offering of Common Stock

January 23rd, 2018

Click to download press release

Rocket Pharmaceuticals and Inotek Pharmaceuticals Complete Merger Transaction

January 4th, 2018

Click to download press release

Rocket Pharmaceuticals Announces Participation in Fireside Chat at Evercore ISI Biopharma Catalyst/Deep Dive Conference

November 27th, 2017

Click to download press release

Inotek Pharmaceuticals Announces Filing of Preliminary Proxy Statement for Proposed Merger with Clinical-stage Gene Therapy Company, Rocket Pharmaceuticals

October 12th, 2017

Click to download press release

Inotek Pharmaceuticals Announces Merger Agreement with Rocket Pharmaceuticals to Advance Pipeline of First-in-Class Gene Therapies for Rare Diseases

September 12th, 2017

Click to download press release
Additional Downloads:
Download Corporate Deck

Contact Information

investors@rocketpharma.com
info@rocketpharma.com

t: 646-440-9100
f: 646-224-9585

Rocket Pharmaceuticals Ltd
The Alexandria Center for Life Science
430 East 29th Street, Suite 1040, NY, NY 10016